4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-21-054302
CIK 0001346830other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 6:07 PM ET
Size
5.2 KB
Accession
0001209191-21-054302
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Sale
Common Stock
2021-08-30$14.20/sh−3,847$54,627→ 141,072 total
Footnotes (1)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 6:07 PM ET
- Size
- 5.2 KB